1 | 1 | | 85R11123 JG-F |
---|
2 | 2 | | By: Miller H.B. No. 4083 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to trauma screening for certain children and |
---|
8 | 8 | | trauma-informed care training for certain providers participating |
---|
9 | 9 | | in the Medicaid managed care program. |
---|
10 | 10 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
11 | 11 | | SECTION 1. Section 266.0042, Family Code, is amended to |
---|
12 | 12 | | read as follows: |
---|
13 | 13 | | Sec. 266.0042. CONSENT FOR PSYCHOTROPIC |
---|
14 | 14 | | MEDICATION. Consent to the administration of a psychotropic |
---|
15 | 15 | | medication is valid only if: |
---|
16 | 16 | | (1) the consent is given voluntarily and without undue |
---|
17 | 17 | | influence; and |
---|
18 | 18 | | (2) the person authorized by law to consent for the |
---|
19 | 19 | | foster child receives verbally or in writing information that |
---|
20 | 20 | | describes: |
---|
21 | 21 | | (A) the specific condition to be treated; |
---|
22 | 22 | | (B) the beneficial effects on that condition |
---|
23 | 23 | | expected from the medication; |
---|
24 | 24 | | (C) the probable health and mental health |
---|
25 | 25 | | consequences of not consenting to the medication; |
---|
26 | 26 | | (D) the probable clinically significant side |
---|
27 | 27 | | effects and risks associated with the medication; [and] |
---|
28 | 28 | | (E) the generally accepted alternative |
---|
29 | 29 | | medications and non-pharmacological interventions to the |
---|
30 | 30 | | medication, if any, and the reasons for the proposed course of |
---|
31 | 31 | | treatment; and |
---|
32 | 32 | | (F) the determination, following a screening of |
---|
33 | 33 | | the foster child for trauma, that the symptoms exhibited by the |
---|
34 | 34 | | foster child are related to a diagnosed mental disorder and not a |
---|
35 | 35 | | traumatic event or that the administration of the psychotropic |
---|
36 | 36 | | medication is recommended for temporary relief for symptoms related |
---|
37 | 37 | | to a traumatic event. |
---|
38 | 38 | | SECTION 2. Section 533.0052, Government Code, is amended to |
---|
39 | 39 | | read as follows: |
---|
40 | 40 | | Sec. 533.0052. STAR HEALTH PROGRAM: TRAUMA-INFORMED CARE |
---|
41 | 41 | | TRAINING. (a) A contract between a managed care organization and |
---|
42 | 42 | | the commission for the organization to provide health care services |
---|
43 | 43 | | to recipients under the STAR Health program must require that: |
---|
44 | 44 | | (1) [include a requirement that trauma-informed care |
---|
45 | 45 | | training be offered to] each contracted physician or provider who |
---|
46 | 46 | | diagnoses mental health conditions or disorders for, prescribes |
---|
47 | 47 | | psychotropic medications for, or provides non-pharmacological |
---|
48 | 48 | | interventions or therapeutic treatment for mental health |
---|
49 | 49 | | conditions or disorders to foster children in the conservatorship |
---|
50 | 50 | | of the Department of Family and Protective Services receives a |
---|
51 | 51 | | minimum of eight hours of trauma-informed care training that the |
---|
52 | 52 | | Department of Family and Protective Services, after consultation |
---|
53 | 53 | | with the Department of State Health Services, considers appropriate |
---|
54 | 54 | | and that includes training on: |
---|
55 | 55 | | (A) attachment theory; |
---|
56 | 56 | | (B) the impact of trauma on a child's: |
---|
57 | 57 | | (i) brain development; |
---|
58 | 58 | | (ii) neurochemistry; |
---|
59 | 59 | | (iii) behavior; and |
---|
60 | 60 | | (iv) cognitive processes and perception; |
---|
61 | 61 | | (C) managing psychological triggers of traumatic |
---|
62 | 62 | | memories; |
---|
63 | 63 | | (D) to reduce the chances of misdiagnosis, |
---|
64 | 64 | | distinctions between symptoms related to trauma exposure and |
---|
65 | 65 | | symptoms related to mental health disorders; |
---|
66 | 66 | | (E) the types and appropriate uses of |
---|
67 | 67 | | non-pharmacological interventions and evidence-based treatment |
---|
68 | 68 | | modalities for trauma; |
---|
69 | 69 | | (F) the factors to consider regarding the |
---|
70 | 70 | | potential use of psychotropic medications by children who have |
---|
71 | 71 | | experienced traumatic events; and |
---|
72 | 72 | | (G) the impact of alcohol use on the brain |
---|
73 | 73 | | development of a child in utero and the impact of fetal alcohol |
---|
74 | 74 | | spectrum disorder on a child's behavior; and |
---|
75 | 75 | | (2) each contracted physician or provider who provides |
---|
76 | 76 | | non-pharmacological interventions or therapeutic treatment to |
---|
77 | 77 | | foster children in the conservatorship of the Department of Family |
---|
78 | 78 | | and Protective Services be certified to use at least one |
---|
79 | 79 | | evidence-based, trauma-informed intervention or therapy that has |
---|
80 | 80 | | received a positive rating for the strength of the research |
---|
81 | 81 | | evidence supporting the intervention or therapy from the California |
---|
82 | 82 | | Evidence-Based Clearinghouse for Child Welfare. |
---|
83 | 83 | | (a-1) The commission shall make the training described by |
---|
84 | 84 | | Subsection (a)(1) available at no cost to each contracted physician |
---|
85 | 85 | | or provider. |
---|
86 | 86 | | (a-2) A contracted physician or provider may meet the |
---|
87 | 87 | | requirements in Subsection (a) by providing documentation to the |
---|
88 | 88 | | commission of relevant training and certification. |
---|
89 | 89 | | (b) The commission shall require [encourage] each managed |
---|
90 | 90 | | care organization providing health care services to recipients |
---|
91 | 91 | | under the STAR Health program to require that each contracted |
---|
92 | 92 | | physician or provider receives [make] training in distinguishing |
---|
93 | 93 | | post-traumatic stress disorder from other mental health disorders, |
---|
94 | 94 | | such as [and] attention-deficit/hyperactivity disorder, bipolar |
---|
95 | 95 | | disorder, and oppositional defiant disorder, not later than |
---|
96 | 96 | | [available to a contracted physician or provider within a |
---|
97 | 97 | | reasonable time after] the date the physician or provider begins |
---|
98 | 98 | | providing services under the managed care plan. |
---|
99 | 99 | | (c) Notwithstanding any other law, a contracted physician |
---|
100 | 100 | | or provider is not required to meet the training and certification |
---|
101 | 101 | | requirements of this section before September 1, 2019. This |
---|
102 | 102 | | subsection expires September 1, 2021. |
---|
103 | 103 | | SECTION 3. (a) Section 533.0052, Government Code, as |
---|
104 | 104 | | amended by this Act, applies only to a contract between the Health |
---|
105 | 105 | | and Human Services Commission and a managed care organization that |
---|
106 | 106 | | is entered into or renewed on or after the effective date of this |
---|
107 | 107 | | Act. |
---|
108 | 108 | | (b) To the extent permitted by law or the terms of the |
---|
109 | 109 | | contract, the Health and Human Services Commission shall amend a |
---|
110 | 110 | | contract entered into before the effective date of this Act with a |
---|
111 | 111 | | managed care organization to require compliance with Section |
---|
112 | 112 | | 533.0052, Government Code, as amended by this Act. |
---|
113 | 113 | | SECTION 4. If before implementing any provision of this Act |
---|
114 | 114 | | a state agency determines that a waiver or authorization from a |
---|
115 | 115 | | federal agency is necessary for implementation of that provision, |
---|
116 | 116 | | the agency affected by the provision shall request the waiver or |
---|
117 | 117 | | authorization and may delay implementing that provision until the |
---|
118 | 118 | | waiver or authorization is granted. |
---|
119 | 119 | | SECTION 5. This Act takes effect September 1, 2017. |
---|